Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor - PubMed (original) (raw)
. 1994 Jul 1;269(26):17741-8.
Affiliations
- PMID: 8021287
Free article
Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor
C Haass et al. J Biol Chem. 1994.
Free article
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the extracellular deposition of amyloid beta-protein (A beta), a molecule produced by post-translational processing of the beta-amyloid precursor protein (beta APP). Mutations within the gene encoding beta APP have been linked to early onset forms of AD, but the pathogenetic mechanism(s) producing the phenotype are unknown. We analyzed the effects on beta APP processing in vitro of a naturally occurring Ala-->Gly mutation at position 692 of beta APP770 (A692G) (Hendriks, L., Duijin, C., Cras, P., Cruts, M., van Hul, W., van Harskamp, F., Warren, A., McInnis, M., Antonarakis, S., Martin, J.-J., Hofman, A., and van Broeckhoven, C. (1992) Nature Genet. 1, 218-221), as well as the effects of five genetically engineered mutations at or near this site. Substitution of glycine or proline for Ala692, or for Phe690, produced relative increases in secretion of A beta and relative decreases in secretion of the p3 peptide(s) arising after alpha-secretase generation of soluble APP (APPs). The Phe690-->Pro substitution also resulted in the synthesis of truncated APPs molecules. The structurally conservative substitutions Ala692-->Val and Phe690-->Tyr did not exhibit these effects. Certain of the substitutions also resulted in the production of a minor peptides, previously undescribed in vitro, beginning at Ala2, Lys16, and Phe19 of A beta. These data show that beta APP mutations carboxyl-terminal to alpha-secretase and beta-secretase cleavage sites can exert strong control over beta APP processing. Increased secretion of A beta may accelerate amyloidogenesis by providing more precursors for aggregation. It is also possible that truncated A beta peptides resulting from several of these mutations may accelerate amyloidogenesis through self-aggregation and/or seeding the fibrillogenesis of longer, more abundant A beta species.
Similar articles
- A basic amino acid in the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein (APP) is essential for cleavage of APP at the alpha-site.
Tomita S, Kirino Y, Suzuki T. Tomita S, et al. J Biol Chem. 1998 Jul 24;273(30):19304-10. doi: 10.1074/jbc.273.30.19304. J Biol Chem. 1998. PMID: 9668120 - Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
Kimura A, Hata S, Suzuki T. Kimura A, et al. J Biol Chem. 2016 Nov 11;291(46):24041-24053. doi: 10.1074/jbc.M116.744722. Epub 2016 Sep 29. J Biol Chem. 2016. PMID: 27687728 Free PMC article. - Production of amyloid beta protein from normal amyloid beta-protein precursor (beta APP) and the mutated beta APPS linked to familial Alzheimer's disease.
Golde TE, Cai XD, Shoji M, Younkin SG. Golde TE, et al. Ann N Y Acad Sci. 1993 Sep 24;695:103-8. doi: 10.1111/j.1749-6632.1993.tb23036.x. Ann N Y Acad Sci. 1993. PMID: 8239266 Review.
Cited by
- Kynurenines, neurodegeneration and Alzheimer's disease.
Kincses ZT, Toldi J, Vécsei L. Kincses ZT, et al. J Cell Mol Med. 2010 Aug;14(8):2045-54. doi: 10.1111/j.1582-4934.2010.01123.x. Epub 2010 Jul 12. J Cell Mol Med. 2010. PMID: 20629991 Free PMC article. Review. - Mint proteins are required for synaptic activity-dependent amyloid precursor protein (APP) trafficking and amyloid β generation.
Sullivan SE, Dillon GM, Sullivan JM, Ho A. Sullivan SE, et al. J Biol Chem. 2014 May 30;289(22):15374-83. doi: 10.1074/jbc.M113.541003. Epub 2014 Apr 17. J Biol Chem. 2014. PMID: 24742670 Free PMC article. - Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.
Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F. Lammich S, et al. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3922-7. doi: 10.1073/pnas.96.7.3922. Proc Natl Acad Sci U S A. 1999. PMID: 10097139 Free PMC article. - Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D, Isaac MG, McCleery J, Tabet N. Jaturapatporn D, et al. Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD006378. doi: 10.1002/14651858.CD006378.pub2. Cochrane Database Syst Rev. 2012. PMID: 22336816 Free PMC article. Review. - Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology.
Xiang Z, Ho L, Yemul S, Zhao Z, Qing W, Pompl P, Kelley K, Dang A, Qing W, Teplow D, Pasinetti GM. Xiang Z, et al. Gene Expr. 2002;10(5-6):271-8. doi: 10.3727/000000002783992352. Gene Expr. 2002. PMID: 12450219 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical